Low-dose tricyclics effective for depression

Article Type
Changed
Fri, 01/18/2019 - 08:39
Display Headline
Low-dose tricyclics effective for depression
PRACTICE RECOMMENDATIONS

Minimum effective dosage and ranges for antidepressants have not been established. While studies suggest that lower-dose tricyclic antidepressants (TCAs) may be as effective as higherdose TCAs, dose comparison studies with other antidepressants have not been conducted.

Low-dose TCAs may not be as effective as standard doses, but they do have fewer treatment dropouts due to side effects, and thus patients may have better long-term compliance. Regular monitoring of patient rate of reduction in severity of depression should be used to help determine optimal individual dosing.

 
Article PDF
Author and Disclosure Information

Practice Recommendations from Key Studies

Furukawa TA, McGuire H, Barbui C. Meta-analysis of effects and side effects of low dosage tricyclic antidepressants in depression: systematic review. BMJ 2002; 325:991–995.

Eugene R. Bailey, MD
Kenneth M. Johnson, III,, MD
Center for Evidence-Based Practice, Department of Family Medicine, SUNY Upstate Medical University, Syracuse, NY

[email protected]

Issue
The Journal of Family Practice - 52(5)
Publications
Topics
Page Number
349-364
Sections
Author and Disclosure Information

Practice Recommendations from Key Studies

Furukawa TA, McGuire H, Barbui C. Meta-analysis of effects and side effects of low dosage tricyclic antidepressants in depression: systematic review. BMJ 2002; 325:991–995.

Eugene R. Bailey, MD
Kenneth M. Johnson, III,, MD
Center for Evidence-Based Practice, Department of Family Medicine, SUNY Upstate Medical University, Syracuse, NY

[email protected]

Author and Disclosure Information

Practice Recommendations from Key Studies

Furukawa TA, McGuire H, Barbui C. Meta-analysis of effects and side effects of low dosage tricyclic antidepressants in depression: systematic review. BMJ 2002; 325:991–995.

Eugene R. Bailey, MD
Kenneth M. Johnson, III,, MD
Center for Evidence-Based Practice, Department of Family Medicine, SUNY Upstate Medical University, Syracuse, NY

[email protected]

Article PDF
Article PDF
PRACTICE RECOMMENDATIONS

Minimum effective dosage and ranges for antidepressants have not been established. While studies suggest that lower-dose tricyclic antidepressants (TCAs) may be as effective as higherdose TCAs, dose comparison studies with other antidepressants have not been conducted.

Low-dose TCAs may not be as effective as standard doses, but they do have fewer treatment dropouts due to side effects, and thus patients may have better long-term compliance. Regular monitoring of patient rate of reduction in severity of depression should be used to help determine optimal individual dosing.

 
PRACTICE RECOMMENDATIONS

Minimum effective dosage and ranges for antidepressants have not been established. While studies suggest that lower-dose tricyclic antidepressants (TCAs) may be as effective as higherdose TCAs, dose comparison studies with other antidepressants have not been conducted.

Low-dose TCAs may not be as effective as standard doses, but they do have fewer treatment dropouts due to side effects, and thus patients may have better long-term compliance. Regular monitoring of patient rate of reduction in severity of depression should be used to help determine optimal individual dosing.

 
Issue
The Journal of Family Practice - 52(5)
Issue
The Journal of Family Practice - 52(5)
Page Number
349-364
Page Number
349-364
Publications
Publications
Topics
Article Type
Display Headline
Low-dose tricyclics effective for depression
Display Headline
Low-dose tricyclics effective for depression
Sections
Disallow All Ads
Article PDF Media

Arthroscopic surgery ineffective for osteoarthritis of the knee

Article Type
Changed
Mon, 01/14/2019 - 10:57
Display Headline
Arthroscopic surgery ineffective for osteoarthritis of the knee

ABSTRACT

BACKGROUND: More than 650,000 arthroscopic procedures are performed each year when medical therapy fails in the treatment of osteoarthritis (OA) of the knee. Uncontrolled studies have shown that up to half of patients receive pain relief from this procedure; however, the exact reason is unclear. There is no evidence that arthroscopic surgery contributes to the cure or arrest in the natural course of OA.

POPULATION STUDIED: The investigators enrolled patients (mean age 52.3 ± 11.3 years) recruited from the Houston Veterans Administration Medical Center who had OA of the knee, as defined by the American College of Rheumatology. The patients reported at least moderate knee pain on average (at least a 4 on a 10-point visual analogue scale) despite at least 6 months of medical treatment. These patients had not undergone arthroscopy in the past 2 years. Patients were excluded for severe pain, severe deformity, and serious medical problems.

STUDY DESIGN AND VALIDITY: This double-blind, randomized controlled trial evaluated 3 treatments: arthroscopic lavage alone, arthroscopic debridement along with lavage, or placebo (“sham”) procedure. Allocation to these groups was appropriately concealed. One orthopedist performed all the operations. The lavage-only group had the joint lavaged with 10 L of fluid and no general debridement was performed. “Bucket-handle” tears to a meniscus or mechanically important deficits were repaired as in the debridement group. The debridement group underwent arthroscopy and joint lavage with 10 L of fluid, shaving of any rough articular surface, removal of debris, and repair of any torn menisci to form a smooth, firm, and fixed rim. Patients in these 2 groups received general anesthesia and were intubated. The placebo procedure simulated debridement by placing three 1-cm incisions in the skin and the surgeon asking for all of the instruments and manipulating the knee as if arthroscopy was being performed. These patients received a short-acting intravenous tranquilizer and an opioid and spontaneously breathed oxygen-enriched air but were not fully anesthetized.

OUTCOMES MEASURED: The primary end point was pain in the study knee 2 years after the intervention, as assessed by a 12-item self-reported Knee-Specific Pain Scale created for this study. The scale ranged from 0 to 100 with higher scores indicating more pain. Five secondary end points were assessed using 2 measures of pain and 3 measures of function.

RESULTS: Mean pain scores for all groups did not differ at any of the recorded time intervals (mean Knee-Specific Pain Scale scores in all 3 groups were 51–54 out of 100). The improvement in pain occurred within the first 2 weeks for all groups (6-to 12-point improvement) and then increased slightly for the remaining 2 years.

 

RECOMMENDATIONS FOR CLINICAL PRACTICE

Arthroscopy does not provide any benefit over “sham surgery” in reducing pain symptoms or physical functioning. Both, probably, had a placebo effect, although the combination of surgery and anesthesia is an expensive and potentially dangerous placebo.

Article PDF
Author and Disclosure Information

 

Eugene R. Bailey, MD
Department of Family Medicine SUNY Upstate Medical University Syracuse
[email protected]

Issue
The Journal of Family Practice - 51(10)
Publications
Topics
Page Number
810-824
Sections
Author and Disclosure Information

 

Eugene R. Bailey, MD
Department of Family Medicine SUNY Upstate Medical University Syracuse
[email protected]

Author and Disclosure Information

 

Eugene R. Bailey, MD
Department of Family Medicine SUNY Upstate Medical University Syracuse
[email protected]

Article PDF
Article PDF

ABSTRACT

BACKGROUND: More than 650,000 arthroscopic procedures are performed each year when medical therapy fails in the treatment of osteoarthritis (OA) of the knee. Uncontrolled studies have shown that up to half of patients receive pain relief from this procedure; however, the exact reason is unclear. There is no evidence that arthroscopic surgery contributes to the cure or arrest in the natural course of OA.

POPULATION STUDIED: The investigators enrolled patients (mean age 52.3 ± 11.3 years) recruited from the Houston Veterans Administration Medical Center who had OA of the knee, as defined by the American College of Rheumatology. The patients reported at least moderate knee pain on average (at least a 4 on a 10-point visual analogue scale) despite at least 6 months of medical treatment. These patients had not undergone arthroscopy in the past 2 years. Patients were excluded for severe pain, severe deformity, and serious medical problems.

STUDY DESIGN AND VALIDITY: This double-blind, randomized controlled trial evaluated 3 treatments: arthroscopic lavage alone, arthroscopic debridement along with lavage, or placebo (“sham”) procedure. Allocation to these groups was appropriately concealed. One orthopedist performed all the operations. The lavage-only group had the joint lavaged with 10 L of fluid and no general debridement was performed. “Bucket-handle” tears to a meniscus or mechanically important deficits were repaired as in the debridement group. The debridement group underwent arthroscopy and joint lavage with 10 L of fluid, shaving of any rough articular surface, removal of debris, and repair of any torn menisci to form a smooth, firm, and fixed rim. Patients in these 2 groups received general anesthesia and were intubated. The placebo procedure simulated debridement by placing three 1-cm incisions in the skin and the surgeon asking for all of the instruments and manipulating the knee as if arthroscopy was being performed. These patients received a short-acting intravenous tranquilizer and an opioid and spontaneously breathed oxygen-enriched air but were not fully anesthetized.

OUTCOMES MEASURED: The primary end point was pain in the study knee 2 years after the intervention, as assessed by a 12-item self-reported Knee-Specific Pain Scale created for this study. The scale ranged from 0 to 100 with higher scores indicating more pain. Five secondary end points were assessed using 2 measures of pain and 3 measures of function.

RESULTS: Mean pain scores for all groups did not differ at any of the recorded time intervals (mean Knee-Specific Pain Scale scores in all 3 groups were 51–54 out of 100). The improvement in pain occurred within the first 2 weeks for all groups (6-to 12-point improvement) and then increased slightly for the remaining 2 years.

 

RECOMMENDATIONS FOR CLINICAL PRACTICE

Arthroscopy does not provide any benefit over “sham surgery” in reducing pain symptoms or physical functioning. Both, probably, had a placebo effect, although the combination of surgery and anesthesia is an expensive and potentially dangerous placebo.

ABSTRACT

BACKGROUND: More than 650,000 arthroscopic procedures are performed each year when medical therapy fails in the treatment of osteoarthritis (OA) of the knee. Uncontrolled studies have shown that up to half of patients receive pain relief from this procedure; however, the exact reason is unclear. There is no evidence that arthroscopic surgery contributes to the cure or arrest in the natural course of OA.

POPULATION STUDIED: The investigators enrolled patients (mean age 52.3 ± 11.3 years) recruited from the Houston Veterans Administration Medical Center who had OA of the knee, as defined by the American College of Rheumatology. The patients reported at least moderate knee pain on average (at least a 4 on a 10-point visual analogue scale) despite at least 6 months of medical treatment. These patients had not undergone arthroscopy in the past 2 years. Patients were excluded for severe pain, severe deformity, and serious medical problems.

STUDY DESIGN AND VALIDITY: This double-blind, randomized controlled trial evaluated 3 treatments: arthroscopic lavage alone, arthroscopic debridement along with lavage, or placebo (“sham”) procedure. Allocation to these groups was appropriately concealed. One orthopedist performed all the operations. The lavage-only group had the joint lavaged with 10 L of fluid and no general debridement was performed. “Bucket-handle” tears to a meniscus or mechanically important deficits were repaired as in the debridement group. The debridement group underwent arthroscopy and joint lavage with 10 L of fluid, shaving of any rough articular surface, removal of debris, and repair of any torn menisci to form a smooth, firm, and fixed rim. Patients in these 2 groups received general anesthesia and were intubated. The placebo procedure simulated debridement by placing three 1-cm incisions in the skin and the surgeon asking for all of the instruments and manipulating the knee as if arthroscopy was being performed. These patients received a short-acting intravenous tranquilizer and an opioid and spontaneously breathed oxygen-enriched air but were not fully anesthetized.

OUTCOMES MEASURED: The primary end point was pain in the study knee 2 years after the intervention, as assessed by a 12-item self-reported Knee-Specific Pain Scale created for this study. The scale ranged from 0 to 100 with higher scores indicating more pain. Five secondary end points were assessed using 2 measures of pain and 3 measures of function.

RESULTS: Mean pain scores for all groups did not differ at any of the recorded time intervals (mean Knee-Specific Pain Scale scores in all 3 groups were 51–54 out of 100). The improvement in pain occurred within the first 2 weeks for all groups (6-to 12-point improvement) and then increased slightly for the remaining 2 years.

 

RECOMMENDATIONS FOR CLINICAL PRACTICE

Arthroscopy does not provide any benefit over “sham surgery” in reducing pain symptoms or physical functioning. Both, probably, had a placebo effect, although the combination of surgery and anesthesia is an expensive and potentially dangerous placebo.

Issue
The Journal of Family Practice - 51(10)
Issue
The Journal of Family Practice - 51(10)
Page Number
810-824
Page Number
810-824
Publications
Publications
Topics
Article Type
Display Headline
Arthroscopic surgery ineffective for osteoarthritis of the knee
Display Headline
Arthroscopic surgery ineffective for osteoarthritis of the knee
Sections
Disallow All Ads
Article PDF Media